Florida Cancer Specialists & Research Institute Announces Installation of New Executive Board
Executive Board to Lead Strategic Vision and Innovation in Community Oncology Care
FORT MYERS, Fla., July 2, 2025 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is proud to announce the installation of its new Executive Board, effective July 1, 2025. The new board is comprised of physician leaders representing each of the practice's six regions across Florida, in addition to one at-large member elected to serve the broader interests of the statewide network.
This board structure ensures that diverse regional perspectives are integrated into decision-making as the practice continues to expand access to world-class cancer care while maintaining its deep roots in the communities it serves.
Newly Installed Executive Board Members Include:
- Lucio N. Gordan, MD, President & Managing Physician
- David Wenk, MD, Assistant Managing Physician
- Paul M. Dodd, MD, First Coast
- Maen Hussein, MD, Central Coast
- Joel Grossman, MD, Paradise Coast
- Vikas Malhotra, MD, Nature Coast
- Hitesh Patel, MD, Suncoast
- Shachar Peles, MD, Treasure Coast
- Sonalee K. Shroff, MD, At-Large Member
"We are excited to welcome this new group of dedicated physician leaders to our Executive Board," said Dr. Gordan. "Each brings a unique perspective and deep commitment to advancing our mission of delivering high-quality, patient-centered cancer care close to home."
"We also extend our deepest appreciation to the outgoing board members whose leadership has helped shape the practice's strategic growth, clinical innovation, and culture of excellence," Dr. Gordan adds.
With the guidance of this new board, FCS is well-positioned to continue driving transformative care models, research initiatives, and innovations in oncology that put patients first.
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its robust clinical research program.
FCS provides patients with access to a wide range of clinical trials, positioning it as a leader in research among private oncology practices in Florida and across the country. In fact, before receiving FDA approval, the majority of new cancer drugs in the U.S. were first made available to patients through participation in clinical trials at FCS.
Our outstanding team of highly trained and dedicated physicians is committed to delivering tailored treatment plans that make the best use of cutting-edge precision oncology advancements to enhance patient outcomes.
View original content to download multimedia:https://www.prnewswire.com/news-releases/florida-cancer-specialists--research-institute-announces-installation-of-new-executive-board-302496844.html
SOURCE Florida Cancer Specialists & Research Institute